Glibenclamide Dosing and Safety Considerations

Special Populations and Dosage Adjustments

• Glibenclamide should be avoided in patients with chronic kidney disease due to accumulation of active metabolites that retain hypoglycemic activity, as recommended by the American College of Clinical Pharmacy 1

Timing and Dose Modifications

• The American Diabetes Association recommends that patients on once-daily glibenclamide should take their dose before the sunset meal (Iftar) during Ramadan fasting, with potential dose reduction to prevent hypoglycemia 2

Drug Interactions

• Glibenclamide may have reduced glucose-lowering effect when combined with acitretin and should be used with caution or avoided in patients taking this medication, according to the American Academy of Dermatology 4

Combination Therapy

• When adding insulin to existing glibenclamide therapy, the American Diabetes Association recommends maintaining the current glibenclamide dose initially unless the patient has frequent hypoglycemia, with a preference for GLP-1 receptor agonists over sulfonylureas like glibenclamide due to lower hypoglycemia risk, weight benefits, and cardiovascular protection 1